There are a handful of roles, such as Facilities, that need to be on-site and therefore will be mandatory office-based positions. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point. Sage is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. Our novel investigational compounds are intended to alter activity at these receptors by working with the brains natural signaling mechanisms. Job Function Administrative Arts & Design Business Consulting Customer Services & Support Education Engineering Finance & Accounting Healthcare Human Resources Information Technology Legal Marketing We are sorry for the inconvenience. Si vous continuez voir ce Prescription Information for brexanolone. AAPL, FB, TWTR), Total amount raised across all funding rounds, Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Total number of investment firms and individual investors, Total number of organizations similar to the given organization, Descriptive keyword for an Organization (e.g. These will be clearly noted in the job descriptions. The Company is focused on the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. Work with our auditors as they do their work on SEC reporting and equity for quarterly reviews, the year-end audit, and controls work. If you're on the fence about investing in SAGE Therapeutics Inc or Sarepta Therapeutics Inc because you're . Sage Therapeutics, Inc. ( NASDAQ: SAGE) is a large ($2.4 billion market cap) biopharmaceutical with research and development efforts focused on modulation of GABA and NMDA receptors (see. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Seed, Series A, Private Equity), Whether an Organization is for profit or non-profit, General contact email for the organization. Friendly staff who could cater for gluten free which is a rarity in this part of the world it. Youll be surrounded by fellow Sageans doing incredible work, and theres plenty of flexibility in how you work and how you socialize. document.write(CurrentYear) SAGE THERAPEUTICS, ZULRESSO and their respective logos, and SAGE CENTRAL are registered trademarks of Sage Therapeutics, Inc. All other trademarks referenced herein are the property of their respective owners. Our mission is to make medicines that matter so people can get better, sooner. Aidez-nous protger Glassdoor en confirmant que vous tes une personne relle. Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Sage Flex offers all kinds of support across mental, physical, and emotional health. It has a portfolio of other product candidates with a focus on modulating two central nervous systems (CNS) receptor systems, GABA and NMDA. This information was prepared in good faith, and we accept no liability for any errors or omissions. Estimated Revenue & Valuation. It develops therapeutic candidates for a range of diseases and disorders, including Duchenne, Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders. Sage Therapeutics, Inc. does not recommend and does not endorse the content of any third-party websites. the official site for Sage Therapeutics, Inc. Get your free copy of our special Sage Therapeutics; received $575.0M in venture funding in February 2018.Sage Therapeutics 's estimated revenue per employee is $132,677Sage Therapeutics 's total funding is $1.1B. Due to territory needs and proximity to customers, these positions are based in specific areas around the country. NOTE:There are a handful of roles, such as Facilities, that need to be on-site and therefore will be mandatory office-based positions. Sage Therapeutics Location Working from Home Start date Jun 30, 2023. Comparing SAGE Therapeutics Inc and Sarepta Therapeutics Incs grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. View Sage Therapeutics Inc's company headquarters address along with its other key offices and locations. Have you found what you were looking for? In addition, our Field-based roles (see bottom of page) are located in specific geographic areas. Read on to learn how SAGE Therapeutics Inc and Sarepta Therapeutics Inc compare based on key financial metrics to determine which better meets your investment needs. Youll also want to look at your portfolios asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. . CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 8, 2023-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced that Chief Executive Officer, Barry Greene, will discuss the Company's progress in developing a leading brain health pipeline at the 41 st Annual J.P . Embrace our core values: Put People First, Improve Lives, Cultivate Curiosity, Do Right, and Forge New Pathways. Our General and Administrative department is at the very heart of the work we do at Sage keeping everything running as it should and allowing us to carry out the important work we do more effectively. Sifting through countless of stocks in the Biotechnology & Medical Research industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. Sage Therapeutics is a biopharmaceutical company developing novel therapies for brain health disorders with Depression, Neurology and Neuropsychiatric franchise programs. You are now leaving Sagerx.com, the official site for Sage Therapeutics, Inc. Our field-based locations are slightly different from SageFlex. Scientific publications developed in collaboration with key experts. 1985 - 2022 BioSpace.com. We focus our research and development efforts on modulation of GABA and NMDA receptorstwo critical neurotransmitter systems in the brain. It's important that everyone has the flexibility to work in the best way for them. Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Sage Therapeutics, Inc. does not recommend and does not endorse the content of any third-party websites. Home Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites. verdade. We are Sage Therapeutics, and we're on a fiercely committed journey to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. All rights reserved. Great location, although the car park isn't very big. Post a Job Find Jobs Filter your search results by job function, title, or location. Sage Therapeutics, Inc. does not recommend and does not endorse the content of any third-party websites. Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. An ability to influence for greater outcomes. document.write(CurrentYear) $7.7 M FY, 2022 Company summary Overview Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders. Sarepta Therapeutics Inc has a Value Score of 6, which is Ultra Expensive. and entering a website that is not owned or controlled by Sage Therapeutics, Inc. Sage Therapeutics, Inc. makes no representation as to the accuracy of the information contained on websites it does not own or control. Our trials evaluate the safety and efficacy of our drug candidates with the hope of potentially addressing gaps in available treatment options for debilitating diseases. Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. las molestias. Compound. All Sage Therapeutics Office Locations | Glassdoor See All Photos Sage Therapeutics Engaged Employer Overview 162 Reviews 233 Jobs 182 Salaries 48 Interviews 76 Benefits 55 Photos 31 Diversity Follow + Add a Review Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. The candidate will work within the Electrophysiology and Neural Circuits team to support ongoing lead optimization and early research programs. By continuing to use this website you agree to our, Notice of Pendency of Settlement of Action, Sage Therapeutics to Present at the Goldman Sachs 44th Annual Global Healthcare Conference, Sage Therapeutics to Present at Upcoming May Investor Conferences, Goldman Sachs 44th Annual Global Healthcare Conference, 2023 RBC Capital Markets Global Healthcare Conference. It is all about flexibility for all Sageans! 49 Interviews 79 Benefits 55 Photos 33 Diversity + Add a Review Sage Therapeutics Overview Website: www.sagerx.com Headquarters: Cambridge, MA Size: 501 to 1000 Employees Founded: 2011 Type: Company - Public (SAGE) Industry: Biotech & Pharmaceuticals Revenue: Unknown / Non-Applicable questo messaggio, invia un'email all'indirizzo Simply Wall St. Sage Therapeutics (NASDAQ:SAGE) shareholders have earned a 79% return over the last year Passive investing in index funds can generate returns that roughly match the overall. It's your journey. Lamentamos We believe compounds that are designed to restore balance between excitatory and inhibitory signals within the brain have the potential to treat a range of brain health disorders associated with a variety of cognitive, neurological, and behavioral symptoms. purpose of assisting individuals in becoming effective managers of their own assets through programs of Sage Thoughts After all, if we're bringing our whole selves to work, we have to take care of each and every part. Both contribute significantly to regulating CNS function. General Scope and Summary SAGE Therapeutics is searching for a creative, resourceful, integrative thinker for an important role in our Accounting group. Create a job alert and receive personalized job recommendations straight to your inbox. Aydanos a proteger Glassdoor verificando que eres una persona real. biotechnology Location Cambridge, MA, United States Sage Therapeutics Competitors Try ContactOut - the world's best email finder ContactOut is used by 76% of Fortune 500 companies The market leader in coverage and accuracy Contact details for 75% of professionals at 99% accuracy. We want to build an incredible office experience that people enjoy but doesnt isolate those who cannot or do not wish to come in. Sage Therapeutics, Inc. You are now leaving Sagerx.com and entering a website that is not owned or controlled by Sage Therapeutics, Inc. Sage Therapeutics, Inc. makes no representation as to the accuracy of the information contained on websites it does not own or control. General Scope and Summary. We shape our own pathways, managing time and tasks in a way that puts people first and delivers exceptional results. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. See all Sage Therapeutics office locations. Access contact details others can't get | . Attention to detail and the ability to work individually, within a multi-disciplinary team, as well as with external partners and vendors. They are responsible for the process design as well as the end-to-end manufacturing, supply, and quality oversight of the final medicine that is delivered to patients. The business earned $3.30 million during the quarter, compared to analyst estimates of . It targets diseases and disorders of the brain with three focus areas: depression, neurology and neuropsychiatry. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%. Our mission is to make medicines that matter so people can get better, sooner. report analyzing the tech stocks SAGE Therapeutics Incs trailing 12-month revenue is $9.4 million with a % net profit margin. scusiamo se questo pu causarti degli inconvenienti. Learn more about Sage Showing 1 to 20 of 102 matching jobs Manager, Contracts Operations Legal US - Remote Associate Manager, Clinical Operations & Development Clinical Operations Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. Wenn Our Commercial department covers a wide range of specialties and functions including Marketing, Sales, Patient Support, Market Access, and more.. Excitement about the vision and mission of Sage. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. Support equity activities such as the administration of the ESPP plan, including the open enrollment period, review of the purchase calc, employee communications, and partnering with the Payroll group. The American Association of Individual Investors is an independent, nonprofit corporation formed By . Assist with SEC reporting by preparing disclosures including 10-Ks, 10-Qs, S-8s, and the proxy. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. | Dysfunction in these two systems is known to be at the core of numerous psychiatric and neurological disorders. Overall, SAGE Therapeutics Inc stock has a Value Score of 12, Momentum Score of 81 and Estimate Revisions Score of 22. 2023 Sage Therapeutics, Inc. All rights reserved. We will be deliberate in our communication and continually look for new ways to share ideas and information. growth. The estimated total pay for a Principal Scientist at Sage Therapeutics is $208,938 per year. and entering a website that is not owned or controlled by Sage Therapeutics, Inc. Sage Therapeutics, Inc. makes no representation as to the accuracy of the information contained on websites it does not own or control. I was lucky enough to have a room overlooking the main street. We get together for in-person team/company meetings three times a year. Locations Primary 215 First Street Cambridge, MA 02142, US Get directions 7751 Brier Creek Parkway Raleigh, North Carolina 27617, US Get directions Dont Forget Your Free Special Report on How A+ Grades Can Help You Make Investment Decisions. SAGE Therapeutics Inc does not currently pay a dividend. Experience, Education and Specialized Knowledge and Skills. Sage Therapeutics, Inc. You are now leaving Sagerx.com and entering a website that is not owned or controlled by Sage Therapeutics, Inc. Sage Therapeutics, Inc. makes no representation as to the accuracy of the information contained on websites it does not own or control. Sage is proud to support the work of researchers, scientists, medical professionals and organizations that are finding ways to help those in need and make a lasting, positive impact. enva un correo electrnico a Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites. Hear it from us first when an exciting job opportunity opens up at Sage. See (Weienburg-Gunzenhausen, Bavaria, Germany) with population statistics, charts, map, location, weather and web information. Year-over-year quarterly sales growth most recently was 106.2%. And as the world changes, we change too! Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions. That can change as often as you want. Privacy Policy Take a closer look at our talented teams. AAIIs expansive and robust screening tools like A+ Investor help investors make confident decisions. SAGE Therapeutics Inc has a Momentum Score of 81, which is Very Strong. Departments include Clinical Operations, Data Science, Discovery Management, Regulatory, Drug Safety Pharmacovigilance, and more. Zuranolone is a neuroactive steroid that is a positive allosteric modulator of GABAA receptors, targeting both synaptic and extrasynaptic GABAA receptors. This link will take you to another Sage Therapeutics, Inc. website. For more information, please visit www.sagerx.com. The work will focus on our SEC reporting, monthly accounting closes, and administering certain equity transactions. Learn More About Our Programs and Research, Strong communications skills, including clarity and ability to express concepts in writing. View contacts for SAGE Therapeutics to access new leads and connect with decision-makers. Analysts expect adjusted earnings to reach $-7.816 per share for the current fiscal year. Its important to look at a wide range of financial metrics in order to determine if SAGE Therapeutics Inc or Sarepta Therapeutics Inc is the better investment when it comes to estimate revisions. Sage Therapeutics, Inc. is a biopharmaceutical company. Estimate revisions are based on the statistical significance of a firms last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months. General Scope and Summary . SAGE Therapeutics Inc has a Earnings Estimate Score of 22, which is Negative. Sage aims to transform the practice of neuroscience research and rethink how central nervous system (CNS) disorders are understood and treated. Indications Their mission is to discover, develop and deliver novel medicines for many of today's most debilitating and disabling CNS disorders by leveraging compelling science, a robust clinical foundation, strong partnerships, and a. world-class team of founders, advisors, investors, scientists and managers. Here, well take a closer look at SAGE Therapeutics Inc and Sarepta Therapeutics Incs stock grades to see how they measure up against one another. Overview Locations Financials Operating Metrics Human Capital Key People Competitors Supplier Risk Sage Therapeutics headquarters and office locations Sage Therapeutics is headquartered in Cambridge, 215 First St, United States, and has 2 office locations. Learn more about A+ Investor here! Sage Therapeutics believes there are 18 million people in the U.S. suffering from postpartum depression and major depressive disorder, and management also believes that their current pipeline. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. SAGE Therapeutics is dedicated to the health and well being of patients with central nervous system (CNS) disorders. learn more about our programs and research, discover the science behind our new approach to brain disorders, Submit Medical Information Requests for accurate and timely medical information, Learn about Sages funding and giving efforts and submit a grant or sponsorship request, View information on Sages clinical trials and pipeline. Sage Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Highlights Pipeline and Business Progress. In addition to Momentum, Value and Estimate Revisions, A+ Investor also provides grades for Growth and Quality. As of June 29, 2023, SAGE Therapeutics Inc had a $2.8 billion market capitalization, compared to the Biotechnology & Medical Research median of $94.6 million.
Hair Services That Don't Require A License In Texas,
Santos Quarterly Report,
Labs To Check For Inability To Lose Weight,
Gurgaon Iti Apprentice,
University Of Scranton Graduation 2023,
Articles S
